November 2, Friday (Day 5)

Session 1: Discovery
Describe the principles of basic immunology. Describe the process of vaccine discovery

09:00-09:30	Historical overview of vaccine Discovery Professor Dr. Kenji Hirayama, Nagasaki University, Japan
09:30-10:30	Vaccines for infection control Professor Dr. Kenji Hirayama, Nagasaki University, Japan
10:30-10:45	Break
10:45-12:15	Vaccines for infection control Professor Dr. Kenji Hirayama, Nagasaki University, Japan
12:15-13:30	Lunch
13:30-14:30	Vaccine Platform Technology and Adjuvant Development (Dr.Arakawa) Dr. Takeshi Arakawa, University of the Ryukyus, Japan

Session 2: Pre-Clinical Development
Describe the process of pre-clinical development of vaccine

14:30-15:00	CMC Dr. Takeshi Arakawa, University of the Ryukyus, Japan
15:00-15:15	Break
15:15-15:45	Immunogenicity and protect activity assessment Dr. Takeshi Arakawa, University of the Ryukyus, Japan
15:45-16:30	Safety assessment:Toxicity test in animals: regional complications, systemic toxicity Dr. Takeshi Arakawa, University of the Ryukyus, Japan

November 6, Tuesday (Day 7)

Session 3: Clinical Development
Describe the process of vaccine clinical development

09:00-10:00	Assessment of pre-clinical information Dr.Daisuke Tsuzuki, Sanofi Pasteur KK. Tokyo, Japan
10:00-10:30	Clinical development plan Dr.Daisuke Tsuzuki, Sanofi Pasteur KK. Tokyo, Japan
10:30-10:45	Break
10:45-11:45	Dose selection and regimen Dr.Daisuke Tsuzuki, Sanofi Pasteur KK. Tokyo, Japan
11:45-13:30	Lunch
13:30-15:45	Case studies Professor Dr. Kenji Hirayama, Nagasaki University, Japan
15:45-16:00	Break
16:00-17:00	Rev and Exam 3 (Module 3) Professor Dr. Kenji Hirayama, Nagasaki University, Japan